A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
Titel:
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
Auteur:
Fountzilas, Christos Chhatrala, Ravi Khushalani, Nikhil Tan, Wei LeVea, Charles Hutson, Alan Tucker, Chris Ma, Wen Wee Warren, Graham Boland, Patrick Iyer, Renuka